Novartis: digital pharma company of the year
pharmafile | September 26, 2014 | News story | Medical Communications, Sales and Marketing | London, McCann Manchester and Red Door Communications, Novartis, pm society
Novartis pipped Bayer and its big pharma rivals Boehringer, Genentech, GSK and Sanofi to the post in receiving the first Digital Pharmaceutical Company of the Year Award at the PM Society Digital Media Awards last night.
The accolade is based on the breadth and depth of their social media engagement, as measured by Symplur, a healthcare social media consultancy.
The sixth PM Society Digital Media Awards event which was presented by TV sports pundit Colin Murray, also featured a fresh new format, including educational content from LinkedIn, iPad stations showcasing finalists’ work and a Tweet Wall.
Agencies McCann Manchester and Red Door Communications won most recognition on the night, each scooping two Gold Awards with the former also taking home a Bronze.
Emotive achieved a Gold, two Silvers and a Bronze, while Langland walked away with a gold and a silver – and RFA Advertising and Marketing will be polishing a Gold and a Bronze.
M3 with MSA Media and Rainmaker, nitrogen, go digital health (part of Virgo Health), Cherry, Real science and Inspired Science all took a Gold home.
Year on year, the results represent a much wider spread of successful agencies, which used to be confined to just a handful of companies with one standout winner.
Client-side, Shire and the World Hepatitis Alliance led the board with two Golds each. Other pharma companies taking home one win each were Rosemount, AstraZeneca, Roche, SPMSD, Actavis+Warner Chilcott, Novo Nordisk, Takeda, Galderma and Bayer Healthcare.
Best digital project or account manager went to Rebeka Morley from Health iQ, and this year the prestigious Digital Pioneer Award was given to Adam Boucher from Novo Nordisk.
Digital awards lead and co-chair of the PM Society, Rachel Farrow, says: “Several campaigns were truly innovative and exciting and demonstrate real progress in digital for pharma.”
Farrow adds: “Importantly, we also saw more clients accompanying agencies to the second round judging this year and those presenting were noticeably better prepared for the questions and time constraints on the day.”
The PM Society Digital Awards are judged in a two-stage process with online submissions shortlisted to finalists who then present in person to judges for 10 minutes and answer questions for five.
A total of 45 judges attended second round judging – predominantly from the pharma industry, in roles spanning marketing, medical and digital and augmented by a handful of creative directors to give agency-side perspective. This year, the teams of judges reviewed 73 finalist entries across 17 categories.
The full list of awards is available here.
Ben Adams
Related Content
PeptiDream and Novartis extend peptide discovery collaboration
PeptiDream has announced the expansion of its peptide discovery collaboration with Novartis Pharma AG.
Novartis shares new data about Fabhalta for IgAN treatment
Novartis has announced new results from a pre-specified interim analysis of its phase 3 APPLAUSE-IgAN …
Novartis shares new data for Zolgensma in children with SMA
Novartis has announced new data to continue the support of the clinical benefits of Zolgensma …
